Foot Anstey advises Agilio Software on Mediapharm purchase

National law firm Foot Anstey has advised Agilio Software, backed by leading global private equity firm Five Arrows, the alternative assets arm of Rothschild & Co, and TA Associates, on the purchase of the entire issued share capital of Mediapharm – a specialist pharmacy e-learning business.

Agilio Software is a leading provider of healthcare operations software and this latest acquisition forms part of the business's ongoing growth journey, marking its expansion into the pharmacy sector.  

This transaction marks the seventh transaction the Foot Anstey team has advised Agilio on.

The Foot Anstey team was formed of Principal Director Emma Clayton, Senior Associate Hannah Duke and Associates Megan Berry, Benjamin Smith and Kirsty Poulton.

Emma Clayton, Principal Director at Foot Anstey, said: "We are delighted to have supported Agilio once again on their latest investment. This is the seventh acquisition we have advised Agilio on and it has been a pleasure to see their growth journey."

Neil Laycock, Chief Executive Officer of Agilio, said: "We are thrilled to welcome Mediapharm to Agilio. This acquisition represents a significant step forward in our mission to enhance and expand our offerings for the healthcare sector. We are very pleased to have received Foot Anstey's support on this latest milestone."